Related references
Note: Only part of the references are listed.Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study
Alexis Maillard et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2022)
Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review
A. Mizrahi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2019)
Nudging In MicroBiology Laboratory Evaluation (NIMBLE): A scoping review
Bradley J. Langford et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2019)
Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC beta-lactamase
Rebekka Kohlmann et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Microbiology Comment Nudge Improves Pneumonia Prescribing
Mary A. Musgrove et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Diagnosis and Treatment of Clostridium difficile in Adults A Systematic Review
Natasha Bagdasarian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The Use of Cefepime for Treating AmpC β-Lactamase-Producing Enterobacteriaceae
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2013)
Acute bacterial skin and skin structure infections: current perspective
Megha Shah et al.
INDIAN JOURNAL OF DERMATOLOGY (2011)